The FDA has accepted for Priority Review the sNDA for finerenone for heart failure with mildly reduced or preserved ejection fraction.
Signals from the epicardium are essential for fetal coronary lymphangiogenesis. VEGFC and VEGFD produced by the epicardium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback